Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood

[1]  B. Budziszewska,et al.  Effect of co-administration of fluoxetine and amantadine on immunoendocrine parameters in rats subjected to a forced swimming test , 2009, Pharmacological reports : PR.

[2]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[3]  M. Maj,et al.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression , 2009, Metabolic Brain Disease.

[4]  G. Skuza,et al.  Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats. , 2008, Pharmacological reports : PR.

[5]  D. Dudek,et al.  Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression. , 2007, Pharmacological reports : PR.

[6]  S. Fallarini,et al.  Stimulation of N-methyl-D-aspartate receptors modulates Jurkat T cell growth and adhesion to fibronectin. , 2007, Biochemical and biophysical research communications.

[7]  K. Kawashima,et al.  Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor α7 subunit gene knockout mice , 2007, Journal of Neuroimmunology.

[8]  R. H. Bonneau,et al.  Modulation of microglia and CD8+ T cell activation during the development of stress-induced herpes simplex virus type-1 encephalitis , 2007, Brain, Behavior, and Immunity.

[9]  T. Yoshino,et al.  The immunosuppressive effects of nicotine during human mixed lymphocyte reaction. , 2007, European journal of pharmacology.

[10]  M. Maes,et al.  Effect of amantadine and imipramine on immunological parameters of rats subjected to a forced swimming test. , 2006, The international journal of neuropsychopharmacology.

[11]  G. Lombardi,et al.  Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation. , 2005, Biochemical and biophysical research communications.

[12]  Y. Ganor,et al.  Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both , 2005, Journal of Neuroimmunology.

[13]  M. Teixeira,et al.  Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC , 2005, Journal of Neuroimmunology.

[14]  A. Kavelaars,et al.  Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter gene , 2005, Journal of Neuroimmunology.

[15]  D. Carpenter,et al.  Rodent lymphocytes express functionally active glutamate receptors. , 2004, Biochemical and biophysical research communications.

[16]  D. Dudek,et al.  Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression. , 2004, Polish journal of pharmacology.

[17]  M. Maes,et al.  Increased mitogen-induced lymphocyte proliferation in treatment resistant depression: a preliminary study. , 2004, Neuro endocrinology letters.

[18]  S. Rossol,et al.  Kinetics of soluble tumour necrosis factor (TNF)‐α receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)‐α alone, IFN‐α plus amantadine or plus ribavirin , 2004 .

[19]  J. Parojčić,et al.  Influence of dissolution media composition on drug release and in‐vitro/in‐vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers , 2004, The Journal of pharmacy and pharmacology.

[20]  G. Skuza,et al.  Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies. , 2004, Polish journal of pharmacology.

[21]  A. Boldyrev,et al.  Effect of NMDA on Production of Reactive Oxygen Species by Human Lymphocytes , 2003, Bulletin of Experimental Biology and Medicine.

[22]  A. Mondal,et al.  Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. , 2003, International immunopharmacology.

[23]  T. Suda,et al.  Amantadine increases l-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats , 2003, Brain Research.

[24]  W. Danysz,et al.  Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats , 2002, Neuropharmacology.

[25]  B. Budziszewska,et al.  The effect of amphetamine sensitization on mouse immunoreactivity. , 2002, Journal of Physiology and Pharmacology.

[26]  S. Mccann,et al.  Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha Release Is Controlled by the Central Nervous System , 2001, Neuroimmunomodulation.

[27]  E. Bosmans,et al.  Anti-Inflammatory Effects of Antidepressants Through Suppression of the Interferon-γ/Interleukin-10 Production Ratio , 2001, Journal of clinical psychopharmacology.

[28]  J. Wang,et al.  Dopamine attenuates the chemoattractant effect of interleukin-8: a novel role in the systemic inflammatory response syndrome. , 2000, Shock.

[29]  D. Dietrich,et al.  Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. , 2000, Bipolar disorders.

[30]  Z. Rogóż,et al.  Synergistic effect of amantadine and imipramine in the forced swimming test. , 2000, Polish journal of pharmacology.

[31]  S. Basu,et al.  Dopamine, a neurotransmitter, influences the immune system , 2000, Journal of Neuroimmunology.

[32]  T. Saibara,et al.  Effect of Sho‐saiko‐to Extract on HGF and TGF‐β Levels of Intraorgans in Liver‐injured Rats after Partial Hepatectomy , 2000, The Journal of pharmacy and pharmacology.

[33]  A. Berghöfer,et al.  Amantadine Revisited: An Open Trial of Amantadinesulfate Treatment in Chronically Depressed Patients with Borna Disease Virus Infection , 1999, Pharmacopsychiatry.

[34]  R. Palmiter,et al.  Dopamine beta-hydroxylase deficiency impairs cellular immunity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  V. Molina,et al.  Chronic Amphetamine Facilitates Immunosuppression in Response to a Novel Aversive Stimulus Reversal by Haloperidol Pretreatment , 1999, Pharmacology Biochemistry and Behavior.

[36]  M. Balestrino,et al.  Blockade of N-methyl-D-aspartate receptor prevents hypoxic neuronal death and cytokine release. , 1997, Neuroimmunomodulation.

[37]  J. Bergquist,et al.  Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. de Groote,et al.  Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. , 1992, Cytokine.

[39]  A. Basta-Kaim,et al.  Stress-induced changes in muscarinic and β-adrenergic binding sites on rat thymocytes and lymphocytes , 1992, Journal of Neuroimmunology.

[40]  H. Nagasawa,et al.  The antiviral drug amantadine has a direct inhibitory effect on T-lymphocytes. , 1989, Immunopharmacology.

[41]  J. Revillard,et al.  Impaired T-dependent immune response in L-dopa treated BALB/c mice. , 1987, Journal of clinical & laboratory immunology.

[42]  Alicia M. Fry,et al.  Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[43]  H. Ichinose,et al.  Changes in cytokines and neurotrophins in Parkinson's disease. , 2000, Journal of neural transmission. Supplementum.

[44]  M. Maes,et al.  Serotonin-Immune Interactions in Major Depression , 2000 .

[45]  A. Sluzewska,et al.  Indicators of immune activation in depressed patients. , 1999, Advances in experimental medicine and biology.

[46]  Y. Hishikawa,et al.  PARTICIPATION OF DOPAMINE AND NOREPINEPHRINE IN THE SECRETION OF INTERLEUKIN-2 AND INTERLEUKIN-6 FROM THE SPLEEN CELLS OF MICE IN DIFFERENT IMMUNE RES PONSES , 1995 .

[47]  R. Perlman,et al.  Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action. , 1995, Immunology.

[48]  J. Rybakowski,et al.  Increased levels of alpha‐1‐acid glycoprotein and interleukin‐6 in refractory depression , 1995 .

[49]  H. Nagasawa,et al.  Inhibition of lymphocyte proliferation by amantadine and its isomer, 2-aminoadamantane; impact on Lyt-2+ T cells while sparing L3T4+ T cells. , 1991, Immunopharmacology.

[50]  J. Revillard,et al.  Selective T cell defects induced by dopamine administration in mice. , 1987, Immunopharmacology and immunotoxicology.

[51]  Update : Drug Susceptibility of Swine-Origin Influenza A ( H 1 N 1 ) Viruses , 2022 .